Aduro BioTech CEO Stephen Isaacs' 2018 pay jumps 26% to $3.4M
Aduro BioTech reports 2018 executive compensation
By ExecPay News
Published: March 29, 2019
Aduro BioTech reported fiscal year 2018 executive compensation information on March 29, 2019.
In 2018, three executives at Aduro BioTech received on average a compensation package of $2.4M, a 27% increase compared to previous year.
Average pay of disclosed executives at Aduro BioTech
Stephen T. Isaacs, Chief Executive Officer, received $3.4M in total, which increased by 26% compared to 2017. 43% of Isaacs' compensation, or $1.5M, was in option awards. Isaacs also received $308K in non-equity incentive plan, $604K in salary, as well as $1.1M in stock awards.
Andrea van Elsas, Chief Scientific Officer, received a compensation package of $2.2M, which increased by 24% compared to previous year. 50% of the compensation package, or $1.1M, was in option awards.
Blaine Templeman, Chief Administrative Officer, earned $1.7M in 2018, a 34% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on March 29, 2019.